Henrik Stenqvist has been appointed as the new executive vice president and chief financial officer of Recipharm.
New hire
Based in the company’s headquarters in Stockholm, Sweden, Stenqvist will report to the company’s CEO, Thomas Eldred. He has 24 years of finance and management experience and previously worked as the chief financial officer of the Meda Group.
“I am very pleased to welcome Henrik, his extensive experience and perspectives in finance, business and strategic development in the pharmaceutical industry make him a great fit for Recipharm as we continue our strong growth path,” said Eldred.
Recipharm is a contract development and manufacturing organisation (CDMO) in the pharmaceutical industry that offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, as well as pharmaceutical product development.